Stocks to sell

A deep dive into SoFi Technologies (NASDAQ:SOFI) stock provides reason enough not to get on board. Those fundamentals will provide the backbone of my argument against investing in SoFi.  Source: rafapress / I would argue that potential investors avoid the buzz and buzzwords around the SPAC gone public financial services company. Specifically, I’d urge investors,
In any other circumstance, Opendoor Technologies (NASDAQ:OPEN) stock may have been a no-brainer investment. Source: PREMIO STOCK/ As you probably know, owning real estate is the epitome of the American Dream — but the paperwork to seal the deal is a veritable nightmare. Opendoor’s digitalization of the buying and selling process is the answer we’ve
Small biotech companies such as Denmark’s Orphazyme (NASDAQ:ORPH) usually have one major product, which pushes them into the spotlight. For ORPH stock, that one product is Arimoclomol. Source: Iryna Imago / Arimoclomol is a drug that could treat the rare progressive genetic disorder called Niemann-Pick Disease Type C (NPC). Investors looking for a breakthrough
The timing of DiDi Global’s (NYSE:DIDI) initial public offering could not have been any better. Insiders and early investors probably knew about the Chinese regulatory crackdown days after its IPO. They lost the least after DIDI stock plunged. Speculators who bought the stock are in for a rough ride next. Source: Piotr Swat /